Indefinite Delivery Contract SPE2DB22D1057

Award Date 9/28/22
Last Date to Order 12/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
  • SPE2DB22D1057
    Indefinite Delivery Contract
  • 107
    Federal Contract Awards

This indefinite delivery contract was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation as a single award prime vendor. The contract provides for the delivery of various pharmaceutical products and medical supplies to support DLA missions. Delivery orders issued against the contract call for items such as insulin syringes, saline solution, pharmaceutical drugs, and medical equipment to be delivered to Conshohocken, Pennsylvania by specified dates, with values ranging from tens to thousands of dollars. Performance is to occur between September 2022 and December 2025 at locations in the contiguous United States. No set-aside provisions are applied to orders placed under the contract.

As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this prime vendor contract enables DLA to fulfill its mandate to provide critical medical supplies and pharmaceuticals to the U.S. military and partners through the establishment of a long-term supply arrangement with Amerisourcebergen Drug Corporation. Delivery orders issued against the contract facilitate the timely procurement of various medical consumables and drugs needed to support military treatment facilities and readiness programs over the three-year ordering period defined in the award.

Generated 1/5/24, 1:52 AM